Stevens-Johnson syndrome after terbinafine therapy.
Rzany
B
B
Mockenhaupt
M
M
Gehring
W
W
Schöpf
E
E
D000935:Antifungal Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine